Deutsche Bank Downgrades ResMed (RMD) to Sell

July 31, 2015 7:32 AM

Deutsche Bank downgraded ResMed (NYSE: RMD) from Hold to Sell with a price target of $53.00 (from $61.00). The change ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found